|
|
||||||||
Insulin-like growth factors regulate growth, differentiation and the maintenance of differentiated functions in numerous cell types. Insulin-like growth factor I (IGF-I) is produced in largest amounts as a circulating hormone by the liver in response to GH. However, the widespread distribution of IGF-I receptors and the production and secretion of IGF-I by almost all tissues suggest that IGF-I uses autocrine and paracrine modes of action, in addition to its endocrine effects (1). The almost ubiquitous activity of IGF-I in stimulating, if not triggering, cell proliferation is well illustrated by the almost general requirement of IGF-I (or high supra-physiological insulin concentrations that activate IGF-I receptors) as a supplement of serum-free culture media for most normal cell types (2). Cancer cells often escape the dependence for exogenous IGF-I because they secrete high levels of IGF-I in response to the transformation by various oncogenes (3). In the mouse embryo fibroblast model, the synergistic
This article has been cited by other articles:
![]() |
K. Krohn and R. Paschke Progress in Understanding the Etiology of Thyroid Autonomy J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3336 - 3345. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |